pyridostigmine bromide has been researched along with Bonnevie-Ullrich Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanew, K; Tanaka, A; Utsumi, A | 1 |
1 other study(ies) available for pyridostigmine bromide and Bonnevie-Ullrich Syndrome
Article | Year |
---|---|
Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
Topics: Adolescent; Adult; Arginine; Body Height; Child; Cholinesterase Inhibitors; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone; Turner Syndrome | 1998 |